<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
76420-168-24
</NDCCode>
<PackageDescription>
2.4 g in 1 BOTTLE (76420-168-24)
</PackageDescription>
<NDC11Code>
76420-0168-24
</NDC11Code>
<ProductNDC>
76420-168
</ProductNDC>
<ProductTypeName>
BULK INGREDIENT
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Cyclobenzaprine Hydrochloride
</NonProprietaryName>
<DosageFormName>
POWDER
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20190911
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Asclemed USA, Inc.
</LabelerName>
<SubstanceName>
CYCLOBENZAPRINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
1
</StrengthNumber>
<StrengthUnit>
g/g
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-10-08
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
11-SEP-19
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>